Literature DB >> 3841502

Synthesis of the metabolites and degradation products of 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3- carboxylic acid (Amoxanox).

K Ukawa, T Ishiguro, H Kuriki, A Nohara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3841502     DOI: 10.1248/cpb.33.4432

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  5 in total

1.  A facile tandem Michael addition/O-cyclization/elimination route to novel chromeno[3,2-c]pyridines.

Authors:  Remani Vasudevan Sumesh; Akilan Malathi; Raju Ranjith Kumar
Journal:  Mol Divers       Date:  2015-03-11       Impact factor: 2.943

2.  Synthesis of deuterium-labelled amlexanox and its metabolic stability against mouse, rat, and human microsomes.

Authors:  Xinmin Gan; Michael W Wilson; Tyler S Beyett; Bo Wen; Duxin Sun; Scott D Larsen; John J G Tesmer; Alan R Saltiel; Hollis D Showalter
Journal:  J Labelled Comp Radiopharm       Date:  2019-04-03       Impact factor: 1.921

3.  Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.

Authors:  Tyler S Beyett; Xinmin Gan; Shannon M Reilly; Andrew V Gomez; Louise Chang; John J G Tesmer; Alan R Saltiel; Hollis D Showalter
Journal:  Bioorg Med Chem       Date:  2018-09-20       Impact factor: 3.641

4.  Convenient one-step synthesis of a medicinally relevant benzopyranopyridine system.

Authors:  Nikolai M Evdokimov; Artem S Kireev; Andrey A Yakovenko; Mikhail Yu Antipin; Igor V Magedov; Alexander Kornienko
Journal:  Tetrahedron Lett       Date:  2006-12-25       Impact factor: 2.415

5.  A new one-pot three-component synthesis of 2,4-diamino-5H-chromeno[2,3-b]pyridine-3-carbonitrile derivatives.

Authors:  Ahmad Shaabani; Fatemeh Hajishaabanha; Hamid Mofakham; Ali Maleki
Journal:  Mol Divers       Date:  2009-05-16       Impact factor: 2.943

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.